Analysis Metabolite Name Measured Value Units Gender Glycemic status Neuropathy
Reversed phase NEGATIVE ION MODEXANTHOSINE (M-H)-7961Peak area normalizedmale Diabetic Neuropathy
Reversed phase NEGATIVE ION MODEXANTHOSINE (M-H)-9011Peak area normalizedmale Normoglycemic Neuropathy
Reversed phase NEGATIVE ION MODEXANTHOSINE (M-H)-10919Peak area normalizedfemale Pre-diabetic Neuropathy
Reversed phase NEGATIVE ION MODEXANTHOSINE (M-H)-10950Peak area normalizedfemale Diabetic no neuropathy
Reversed phase NEGATIVE ION MODEXANTHOSINE (M-H)-11136Peak area normalizedmale Pre-diabetic Neuropathy
Reversed phase NEGATIVE ION MODEXANTHOSINE (M-H)-11403Peak area normalizedmale Diabetic Neuropathy
Reversed phase NEGATIVE ION MODEXANTHOSINE (M-H)-11776Peak area normalizedmale Diabetic no neuropathy
Reversed phase NEGATIVE ION MODEXANTHOSINE (M-H)-12230Peak area normalizedmale Diabetic no neuropathy
Reversed phase NEGATIVE ION MODEXANTHOSINE (M-H)-12273Peak area normalizedmale Normoglycemic no neuropathy
Reversed phase NEGATIVE ION MODEXANTHOSINE (M-H)-12615Peak area normalizedfemale Pre-diabetic Neuropathy
Reversed phase NEGATIVE ION MODEXANTHOSINE (M-H)-12845Peak area normalizedmale Normoglycemic no neuropathy
Reversed phase NEGATIVE ION MODEXANTHOSINE (M-H)-13895Peak area normalizedfemale Pre-diabetic no neuropathy
Reversed phase NEGATIVE ION MODEXANTHOSINE (M-H)-15927Peak area normalizedfemale Pre-diabetic no neuropathy
Reversed phase NEGATIVE ION MODEXANTHOSINE (M-H)-16536Peak area normalizedfemale Pre-diabetic no neuropathy
Reversed phase NEGATIVE ION MODEXANTHOSINE (M-H)-2818977Peak area normalizedmale Pre-diabetic Neuropathy
Reversed phase NEGATIVE ION MODEXANTHOSINE (M-H)-Peak area normalizedfemale Diabetic Neuropathy
Reversed phase NEGATIVE ION MODEXANTHOSINE (M-H)-Peak area normalizedfemale Diabetic no neuropathy
Reversed phase NEGATIVE ION MODEXANTHOSINE (M-H)-Peak area normalizedfemale Pre-diabetic Neuropathy
Reversed phase NEGATIVE ION MODEXANTHOSINE (M-H)-Peak area normalizedfemale Pre-diabetic no neuropathy
Reversed phase NEGATIVE ION MODEXANTHOSINE (M-H)-Peak area normalizedmale Diabetic Neuropathy
Reversed phase NEGATIVE ION MODEXANTHOSINE (M-H)-Peak area normalizedmale Diabetic no neuropathy
Reversed phase NEGATIVE ION MODEXANTHOSINE (M-H)-Peak area normalizedmale Normoglycemic Neuropathy
Reversed phase NEGATIVE ION MODEXANTHOSINE (M-H)-Peak area normalizedmale Pre-diabetic no neuropathy
Reversed phase POSITIVE ION MODEXANTHOSINE (M+H)+789Peak area normalizedfemale Diabetic Neuropathy
Reversed phase POSITIVE ION MODEXANTHOSINE (M+H)+1206Peak area normalizedfemale Pre-diabetic no neuropathy
Reversed phase POSITIVE ION MODEXANTHOSINE (M+H)+1300Peak area normalizedmale Normoglycemic Neuropathy
Reversed phase POSITIVE ION MODEXANTHOSINE (M+H)+1320Peak area normalizedmale Diabetic Neuropathy
Reversed phase POSITIVE ION MODEXANTHOSINE (M+H)+1330Peak area normalizedmale Diabetic no neuropathy
Reversed phase POSITIVE ION MODEXANTHOSINE (M+H)+1354Peak area normalizedfemale Diabetic Neuropathy
Reversed phase POSITIVE ION MODEXANTHOSINE (M+H)+1546Peak area normalizedmale Diabetic Neuropathy
Reversed phase POSITIVE ION MODEXANTHOSINE (M+H)+1634Peak area normalizedmale Normoglycemic no neuropathy
Reversed phase POSITIVE ION MODEXANTHOSINE (M+H)+1661Peak area normalizedmale Diabetic no neuropathy
Reversed phase POSITIVE ION MODEXANTHOSINE (M+H)+1745Peak area normalizedfemale Pre-diabetic no neuropathy
Reversed phase POSITIVE ION MODEXANTHOSINE (M+H)+1800Peak area normalizedfemale Pre-diabetic Neuropathy
Reversed phase POSITIVE ION MODEXANTHOSINE (M+H)+1962Peak area normalizedfemale Pre-diabetic Neuropathy
Reversed phase POSITIVE ION MODEXANTHOSINE (M+H)+2144Peak area normalizedmale Diabetic no neuropathy
Reversed phase POSITIVE ION MODEXANTHOSINE (M+H)+2183Peak area normalizedmale Diabetic Neuropathy
Reversed phase POSITIVE ION MODEXANTHOSINE (M+H)+2196Peak area normalizedfemale Pre-diabetic no neuropathy
Reversed phase POSITIVE ION MODEXANTHOSINE (M+H)+2264Peak area normalizedmale Pre-diabetic no neuropathy
Reversed phase POSITIVE ION MODEXANTHOSINE (M+H)+2383Peak area normalizedfemale Pre-diabetic Neuropathy
Reversed phase POSITIVE ION MODEXANTHOSINE (M+H)+2509Peak area normalizedmale Pre-diabetic no neuropathy
Reversed phase POSITIVE ION MODEXANTHOSINE (M+H)+2956Peak area normalizedfemale Diabetic no neuropathy
Reversed phase POSITIVE ION MODEXANTHOSINE (M+H)+3048Peak area normalizedfemale Pre-diabetic no neuropathy
Reversed phase POSITIVE ION MODEXANTHOSINE (M+H)+3120Peak area normalizedmale Pre-diabetic Neuropathy
Reversed phase POSITIVE ION MODEXANTHOSINE (M+H)+3284Peak area normalizedfemale Diabetic no neuropathy
Reversed phase POSITIVE ION MODEXANTHOSINE (M+H)+3367Peak area normalizedmale Normoglycemic Neuropathy
Reversed phase POSITIVE ION MODEXANTHOSINE (M+H)+7242Peak area normalizedmale Pre-diabetic Neuropathy
Reversed phase POSITIVE ION MODEXANTHOSINE (M+H)+Peak area normalizedfemale Pre-diabetic Neuropathy
Reversed phase POSITIVE ION MODEXANTHOSINE (M+H)+Peak area normalizedmale Normoglycemic no neuropathy

Return to search page
  logo